engleski

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolaemia Panel

Everyone with familial hypercholesterolaemia has an increased lifetime risk fir atherosclerotic cardiovascular disease, but a group with enhanced risk can be identified. In addition to patients with symptomatic atherosclerotic cardiovascular disease, this group included individuals with the highest levels lf LDL cholesterol, those with advanced subclinical coronary atherosclerosis, and people with additional risk factors for atherosclerotic cardiovascular disease.

Familial hypercholesterolaemia (FH) ; treatment ; PCSK9 inhibitors ; mipomersen ; lomitapide

nije evidentirano